HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

474.840

+5.7291.22%

Number of Gainers:22

Number of Losers:26

Number of Flat:3

PE:- -

High:475.049

Open:468.227

Low:465.418

Close:469.111

Volume:344.48M

Turnover:10.06B

Market Cap:2.97T

Float Cap:2.09T

Loading ...

3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion

Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth

Morgan Stanley Trims China Resources Beer Target to HK$30, Keeps Overweight Stance

Meituan's Food Delivery Platform Introduces New Location-Based Store Tags for Enhanced User Experience

China Resources Beer's Baijiu Business Likely to Only Recover in Longer Term

Luye Pharma's Vaccine for Cervical Precancerous Lesions to Enter Phase II Trial

MT Newswires Live

Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains

Shareholder Offloads Nearly 7 Billion Yuan in Precision-Timed Selloff, Stake Drops to 3.79%

Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth

ZYLOXTB Surges Over 9% Intraday on Strong H1 Net Profit of 179 Million Yuan, Up 47.8% Year-On-Year

Simcere Pharmaceutical Group's H1 Attributable Profit Rises 38%

MT Newswires Live

Press Release: Sunshine Guojian Releases 2026 Interim Report:

Everest Medicines Limited (HKG:1952) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Simply Wall St.

Canada's Diamond Estates Q1 Revenue Falls on Lower Winery Shipments

Keymed Biosciences (SEHK:2162) Stock Questions Whether New Profit Can Last

Simply Wall St.

Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%

THOMSON REUTERS

Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis

Simcere Pharma Appoints Zhu Da as Joint Company Secretary

China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BK1583/news?page=23"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":474.84,"timestamp":1788335729909,"preClose":469.11102,"halted":0,"volume":344483773,"delay":0,"changeRate":0.012212,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":5.728973,"latestTime":"09-02 15:55:30","open":468.22687,"high":475.04938,"low":465.4181,"amount":10063295410,"amplitude":0.020531,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788336600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"pbRate":2.123393,"peRate":44.857386,"turnoverRate":0.003352,"increases":22,"decrements":26,"flats":1,"marketCap":2973929404768,"floatMarketCap":2088340713536},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":475.04938,"amplitude":0.020531,"preClose":469.11102,"low":465.4181,"pbRate":"2.123393","latestPrice":474.84,"volume":344483773,"delay":0,"open":468.22687,"prevYearClose":503.90085,"prevWeekClose":483.681,"prevMonthClose":473.951,"prevQuarterClose":402.118,"fiveDayClose":483.092,"twentyDayClose":476.028,"sixtyDayClose":414.418,"secType":"PLATE","market":"HK","turnoverRate":0.003352,"peRate":44.857386,"marketCap":2973929404768,"floatMarketCap":2088340713536,"timestamp":1788335729909,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":22,"down":26,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:23,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661250205","title":"3SBio H1 FY26 Net Profit Rises 26.5% to RMB 1.44 Billion; Revenue Increases 3.9% to RMB 4.53 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250205","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250205?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:25","pubTimestamp":1787297118,"startTime":"0","endTime":"0","summary":"3SBio H1 FY26 net profit rises 26.5% to RMB 1.44 billion; revenue increases 3.9% to RMB 4.53 billion3SBio posted first-half 2026 revenue of RMB 4.53 billion, up 3.9% year over year.Net profit attribut","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDLb6tQZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","BK1161","HK0000165453.HKD","BK1593","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250247","title":"Press Release: 3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250247","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250247?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:24","pubTimestamp":1787297040,"startTime":"0","endTime":"0","summary":"SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, represent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK4232","BK1161","01530","R","IDNA","HYLG","GDOC","NVIB","BK4022","HK0000165453.HKD","BMED","MEDX","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661825746","title":"Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661825746","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661825746?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:40","pubTimestamp":1787294458,"startTime":"0","endTime":"0","summary":"Norway's Medistim Q2 revenue rises on own-product sales growthOverviewNorway medical device maker's Q2 revenue grew 19.5% yr/yr to NOK 202 mlnQ2 operating profit (EBIT) rose 20.6% to NOK 65.3 mln, EBI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I05U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1583","02190","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189134175","title":"Morgan Stanley Trims China Resources Beer Target to HK$30, Keeps Overweight Stance","url":"https://stock-news.laohu8.com/highlight/detail?id=1189134175","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189134175?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:14","pubTimestamp":1787292862,"startTime":"0","endTime":"0","summary":"Morgan Stanley has lowered its target price for China Resources Beer (00291) from HK$35 to HK$30 in its latest research report, while maintaining an \"Overweight\" rating on the stock. The adjustment...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1604","LU1794554557.SGD","IE00B031HY20.USD","BK1521","IE0031814852.USD","BK1583","BK1570","LU0359201612.USD","IE00B543WZ88.USD","EWH","BK1510","IE00BPRC5H50.USD","00291","SG9999006514.SGD","LU0359202008.SGD","IE00B29SXG58.USD","LU1720050803.USD","IE00B0169L03.USD","IE0008369823.USD","LU1023057109.AUD","IE00B5MMRT66.SGD","LU0328353924.USD","CRHKY","BK1589","IE0008368742.USD","LU1769817096.USD","80291","LU1769817179.HKD","LU1328615791.USD","BK1180","BK1578"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162343482","title":"Meituan's Food Delivery Platform Introduces New Location-Based Store Tags for Enhanced User Experience","url":"https://stock-news.laohu8.com/highlight/detail?id=1162343482","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162343482?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:01","pubTimestamp":1787292069,"startTime":"0","endTime":"0","summary":"As of August this year, over 200,000 merchants on Meituan's food delivery platform have adopted the new \"Mall Store\" tag, while 45,000 businesses have showcased the \"Commercial Street Store\" label,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","LU1813983027.USD","LU2097828557.USD","LU0672654166.SGD","LU0823041008.USD","LU1102505929.USD","LU0823426480.USD","LU0054450605.USD","LU0593848301.USD","LU1102505762.USD","LU1675838814.USD","IE0032431581.USD","IE00B3M56506.USD","LU2257852520.SGD","LU0577902538.SGD","LU0164865239.USD","LU0417516902.SGD","LU0502904849.HKD","LU0611395673.USD","LU1880383366.USD","LU0456827905.SGD","LU0315178854.USD","LU0588545904.SGD","LU0214875030.USD","LU0348816934.USD","LU0700851271.USD","BK1591","LU0117841782.USD","LU1242518857.USD","LU0417516738.SGD","LU0878005551.USD","LU2152927971.USD","LU1328277881.USD","SG9999000459.SGD","LU0633140560.USD","LU0149721374.USD","LU0577902371.SGD","LU0819121731.USD","LU1481107354.HKD","LU0143863784.USD","LU1048588211.SGD","LU0165289439.USD","LU0577902298.EUR","SG9999014674.SGD","LU0605514214.HKD","LU2488822045.USD","BK1604","KWEB","LU0049853897.USD","LU0132412106.USD","LU1961090484.USD","LU1770036033.HKD","BK1142","LU0499858602.USD","LU1064131003.USD","LU0650527681.SGD","LU1224709979.USD","LU1688375341.USD","BK1521","LU0918141887.USD","LU2476274720.SGD","BK1233","LU0348814723.USD","LU0541501648.USD","LU1831875114.USD","LU0067412154.USD","LU0348788117.USD","LU0540923850.HKD","LU1242518931.SGD","LU1770034418.SGD","LU0052750758.USD","LU1868838027.USD","LU2242644610.SGD","IE00B5MMRT66.SGD","IE00BF5LJ272.USD","BK1610","LU2039709279.SGD","LU0128522157.USD","LU2476274308.USD","LU0819123356.HKD","LU0828237510.HKD","LU1048596156.SGD","LU1993786604.SGD","LU2399975544.HKD","LU2097828474.EUR","LU0047713382.USD","LU0048597586.USD","LU0456846285.SGD","LU2097828714.EUR","LU0039217434.USD","IE0008368742.USD","SG9999001689.USD","BK1615","LU0979878070.USD","IE00B543WZ88.USD","LU2148510915.USD","IE00B0JY6N72.USD","LU0307460666.USD","LU0865486749.SGD","LU0918141705.HKD","LU0509642566.USD","LU0455707207.USD","LU0797268264.HKD","LU0048580855.USD","LU0244354667.USD","LU0326948709.USD","LU0821914370.USD","LU0287142896.SGD","LU0072462343.USD","LU2226246903.HKD","LU0269904917.USD","LU1064130708.USD","LU0140636845.USD","LU0072913022.USD","LU1152091168.USD","LU1152091754.HKD","LU0345775950.USD","LU0210526637.USD","LU2097828631.EUR","LU0823426308.USD","LU0106252389.USD","LU0880133367.SGD","LU0871576103.HKD","LU0164880469.USD","LU0531971595.HKD","LU0173614495.USD","LU1282648689.USD","LU2045819591.USD","LU1868837722.USD","SG9999002828.SGD","LU0572944931.SGD","LU0359202008.SGD","LU1188198961.HKD","LU0320764599.SGD","LU1023057109.AUD","LU0211977185.USD","LU0499858438.USD","LU0348805143.USD","LU0856984785.SGD","LU1008478684.HKD","LU1734074674.USD","SG9999002562.SGD","LU0348827113.USD","LU0873338254.USD","LU0043850808.USD","LU0143863198.USD","LU0196878994.USD","LU0823039010.USD","SG9999001903.USD","LU1880383440.USD","SG9999002463.SGD","LU0011963245.USD","LU0348825331.USD","LU0594300179.USD","LU1794554557.SGD","LU0054237671.USD","LU0431992006.USD","LU1807302812.USD","LU0314109678.HKD","LU1105468828.SGD","LU0594300419.USD","LU2125910500.SGD","LU0577902611.USD","LU1868837565.USD","LU0588545490.SGD","LU0449515922.USD","LU0326950275.SGD","METmain","LU0348735423.USD","MPNGY","LU0320764755.SGD","LU0228659784.USD","LU0708995583.HKD","LU0868486357.SGD","IE00B29SXG58.USD","LU0588546209.SGD","HMTD.SI","LU1808992512.USD","LU1960683339.HKD","IE0008369823.USD","LU0359201885.HKD","BK1583","LU0029875118.USD","LU0561508036.HKD","LU0828237940.HKD","LU1251922891.USD","LU1323998911.USD","LU0589944569.HKD","LU0737861699.HKD","SG9999000327.SGD","03690","LU0051755006.USD","LU0345776255.USD","LU0577902454.USD","LU2097828805.USD","LU0231483743.USD","BK1589","LU0359201612.USD","LU0683595622.HKD","LU0828238088.HKD","LU1719994722.HKD","LU0181495838.USD","LU0588545730.USD","LU2778985437.USD","LU0261950983.USD","LU0634319403.HKD","LU0823038988.USD","LU0463099449.HKD","IE0034224299.USD","IE00B031HY20.USD","IE00BPRC5H50.USD","LU0449509016.USD","LU0164872284.USD","LU0084288322.USD","LU0541502299.USD","LU0543330483.HKD","LU0633140727.USD","LU1226287529.USD","BK1575","BK1618","LU1303224171.USD","LU0370786039.SGD","LU0251144936.SGD","LU1720050803.USD","LU0501845795.SGD","LU2087589342.USD","LU0823040885.USD","LU1328615791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661252618","title":"China Resources Beer's Baijiu Business Likely to Only Recover in Longer Term","url":"https://stock-news.laohu8.com/highlight/detail?id=2661252618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661252618?lang=en_us&edition=fundamental","pubTime":"2026-08-21 13:53","pubTimestamp":1787291580,"startTime":"0","endTime":"0","summary":"0553 GMT - China Resources Beer's baijiu business is likely to only recover in the longer term, after the segment's 1H revenue missed estimates, say China Galaxy International analysts in a note. The brewer said in an analyst briefing it is avoiding direct-to-consumer pushes for baijiu--a Chinese distilled liquor--to ease elevated channel inventory and distributor liquidity constraints, they note. The company is instead introducing a third-party custody or consignment model for its new baijiu stock-keeping units, where it will absorb inventory fluctuation to rebuild channel confidence. CGI cuts its 2026-2028 earnings-per-share estimates by 3.7%-3.8% on a weaker baijiu business and higher-than-expected cost pressure. It trims its target price to 31.30 Hong Kong dollars from HK$33.50. Shares rise 2.3% to HK$21.02.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1578","LU1769817179.HKD","SG9999006514.SGD","IE00B29SXG58.USD","IE00B5MMRT66.SGD","LU1328615791.USD","BK1570","00291","IE00BPRC5H50.USD","LU1769817096.USD","IE00B543WZ88.USD","BK1180","IE0031814852.USD","IE0008369823.USD","IE00B0169L03.USD","LU0359202008.SGD","LU1023057109.AUD","LU0359201612.USD","BK1583","80291","BK1510","LU1720050803.USD","IE00B031HY20.USD","LU1794554557.SGD","CRHKY","LU0328353924.USD","IE0008368742.USD","BK1589","BK1521","BK1604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661804252","title":"Luye Pharma's Vaccine for Cervical Precancerous Lesions to Enter Phase II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661804252","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661804252?lang=en_us&edition=fundamental","pubTime":"2026-08-21 13:36","pubTimestamp":1787290567,"startTime":"0","endTime":"0","summary":"Luye Pharma Group  said its LY01620 therapeutic mRNA vaccine for cervical precancerous lesions is set to enter a Phase II clinical trial in China.The trial will assess the candidate's safety and efficacy in patients with HPV16-positive high-grade cervical lesions, according to a Thursday Hong Kong exchange filing. Positive results from a Phase I study supported the move into Phase II, the company said in the filing.Shares of the company rose nearly 2% in recent trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1606","02186","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100118644","title":"Morning Market Pulse: Hang Seng Index Climbs 0.72% in Early Session, Lithium Miners Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1100118644","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100118644?lang=en_us&edition=fundamental","pubTime":"2026-08-21 12:09","pubTimestamp":1787285378,"startTime":"0","endTime":"0","summary":"Hong Kong equities advanced in Thursday's morning session, with the benchmark Hang Seng Index adding 184 points to trade 0.72% higher, while the Hang Seng Tech Index gained 0.50%. Total turnover in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1586","BK1207","BK1113","LU0572940350.SGD","BK1543","LU1993786604.SGD","BK1240","07226","07500","LU0264606111.USD","LU0307460666.USD","BK1522","01772","02788","02837","07300","BK1592","HSTECH","601869","00189","LU1251922891.USD","SG9999014674.SGD","03088","HK0000165453.HKD","BK1518","HK0000500386.USD","BK1513","513600","LU0359201885.HKD","BK1190","LU1171460220.USD","HTImain","LU0210526637.USD","09696","LU0287142896.SGD","HHImain","SG9999003461.SGD","BK1593","03419","BK1594","07552","BK1161","HK0000252160.HKD","HSImain","LU0067412154.USD","BK1117","03032","07200","01378","HK0000286598.CNH","03750","09088","HK0000914660.USD","SG9999006597.SGD","02800","02600","LU1303224171.USD","BK1129","09115","LU1023057109.AUD","LU0737861699.HKD","BK1116","02706","002466","LU0359202008.SGD","BK1511","002460","06869","LU0345780950.USD","BK1500","LU0359201612.USD","BK1155","BK1589","LU0469268626.HKD","BK1509","00354","HK0001040168.HKD","BK1506","MCHmain","LU1808992512.USD","HK0000252152.HKD","BK1526","LU0630314457.HKD","06896","LU0051755006.USD","LU0880133367.SGD","LU1224709979.USD","LU1719994722.HKD","BK1610","BK1175","LU1960683339.HKD","300750","09067","LU0588546209.SGD","LU0173614495.USD","LU2279858448.HKD","LU1807302812.USD","BK1523","LU1770034418.SGD","03417","LU1152091754.HKD","LU0572939691.SGD","HK0001040143.USD","03033","03115","LU0345781412.USD","HK0000914686.HKD","03037","BK1601","LU1152091168.USD","BK1149","01866","HLDCY","LU0456827905.SGD","LU1166156734.SGD","83115","SG9999001093.SGD","02833","HSI","06656","03067","BK1559","00012","BK1568","LU0702159699.USD","LU1008478684.HKD","BK1583","BK1170","01530","82800","03423","601600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116733066","title":"Shareholder Offloads Nearly 7 Billion Yuan in Precision-Timed Selloff, Stake Drops to 3.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116733066","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116733066?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:41","pubTimestamp":1787283701,"startTime":"0","endTime":"0","summary":"A late-night announcement on August 19 from JUNSHI BIO (688180.SH) brought the curtain down on a two-month reduction campaign by major shareholder Shanghai Tanying Investment Partnership (Limited...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1515","BK1161","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185563343","title":"Hong Kong Stock Alert: 3SBIO Surges Over 7% on Strong First-Half Adjusted Operating Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1185563343","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185563343?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:30","pubTimestamp":1787279417,"startTime":"0","endTime":"0","summary":"3SBIO (01530) shares climbed more than 7% in early trading, with the stock last up 6.85% at HK$17.63, on turnover of HK$395 million. The surge follows the company's release of its 2026 interim...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","KCAI","BK1593","BK4588","BK1583","BK1161","01530","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108482719","title":"ZYLOXTB Surges Over 9% Intraday on Strong H1 Net Profit of 179 Million Yuan, Up 47.8% Year-On-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1108482719","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108482719?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:10","pubTimestamp":1787278248,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) saw its shares climb more than 9% following the release of its interim results, before settling to a gain of 5.48% at 20.78 Hong Kong dollars, with turnover reaching 21.85 million...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02190","BK1587","BK1574","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256997","title":"Simcere Pharmaceutical Group's H1 Attributable Profit Rises 38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256997","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256997?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:56","pubTimestamp":1787277410,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group  posted an attributable net profit of 828.7 million yuan in the first half, up 37.9% from 601.1 million yuan a year ago.Earnings per share came in at 0.32 yuan, up from 0.25 yuan a year earlier, according to a Friday filing with the Hong Kong Stock bourse.Total revenue in the six months ended June 30 increased to 4.58 billion yuan from 3.59 billion yuan.The company did not declare an interim dividend.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","BK1583","02096","FCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258777","title":"Press Release: Sunshine Guojian Releases 2026 Interim Report:","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258777","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258777?lang=en_us&edition=fundamental","pubTime":"2026-08-21 08:00","pubTimestamp":1787270400,"startTime":"0","endTime":"0","summary":"Innovation-driven, Steady AdvancementSHANGHAI, Aug. 20, 2026 /PRNewswire/ -- Today, Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (hereinafter referred to as \"Sunshine Guojian\", stock code: 688","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","IDNA","MEDX","NVIB","R","BK1593","GDOC","01530","HK0000165453.HKD","BK1583","BK4022","BK4232","BK0239","688336","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256976","title":"Everest Medicines Limited (HKG:1952) Interim Results Just Came Out: Here's What Analysts Are Forecasting For This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256976","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661256976?lang=en_us&edition=fundamental","pubTime":"2026-08-21 06:51","pubTimestamp":1787266310,"startTime":"0","endTime":"0","summary":"It's been a pretty great week for Everest Medicines Limited ( HKG:1952 ) shareholders, with its shares surging 18% to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-limited-hkg1952-interim-results-just-came","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1952/everest-medicines-shares/news/everest-medicines-limited-hkg1952-interim-results-just-came","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","01952","PMDE","FEBU","MDCO","JOYT","BK1574","GXDW","VGFPF","VOTE","BK1583","RGLO","DECU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661370942","title":"Canada's Diamond Estates Q1 Revenue Falls on Lower Winery Shipments","url":"https://stock-news.laohu8.com/highlight/detail?id=2661370942","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661370942?lang=en_us&edition=fundamental","pubTime":"2026-08-21 05:40","pubTimestamp":1787262037,"startTime":"0","endTime":"0","summary":"Canada's Diamond Estates Q1 revenue falls on lower winery shipmentsOverviewCanada wine and spirits producer's Q1 2027 revenue fell 15% yr/yr on lower winery shipmentsGross margin rose to 61.1% of reve","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H122:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B0169L03.USD","IE00B29SXG58.USD","LU0359202008.SGD","BK1570","LU0359201612.USD","IE00B543WZ88.USD","BK1589","BK1578","80291","BK1583","LU0328353924.USD","IE0008368742.USD","BK1604","BK1521","BK1180","LU1720050803.USD","IE00BPRC5H50.USD","00291","IE00B031HY20.USD","LU1023057109.AUD","LU1769817096.USD","IE00B5MMRT66.SGD","LU1769817179.HKD","CRHKY","LU1328615791.USD","IE0008369823.USD","SG9999006514.SGD","LU1794554557.SGD","IE0031814852.USD","BK1510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661303292","title":"Keymed Biosciences (SEHK:2162) Stock Questions Whether New Profit Can Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2661303292","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661303292?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257986,"startTime":"0","endTime":"0","summary":"Keymed Biosciences stock has cooled in recent weeks, with the share price down about 10.6% over the past month even after moving into the black over the last year. Today's earnings story is all about profit, not hype. Basic earnings per share for the first half of 2026 came in at ¥4.29, flipping from losses in 2025, and trailing twelve month earnings now support a P/E of 25.4x.\nThe market is treating that P/E as a question mark. The key issue now is whether investors see this new...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-sehk2162-stock-questions-whether-new-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-sehk2162-stock-questions-whether-new-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1574","BK1587","02162","JOYT","RGLO","VGFPF","VOTE","FEBU","DECU","BK1583","GXDW","PMDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660233120","title":"Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660233120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660233120?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:10","pubTimestamp":1787238639,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUACZXYM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","02190","BK1574","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161013794","title":"Simcere Pharma's Half-Year Profit Jumps 48.7% on Adjusted Basis","url":"https://stock-news.laohu8.com/highlight/detail?id=1161013794","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161013794?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238152,"startTime":"0","endTime":"0","summary":"Simcere Pharma (02096) has announced its interim results for 2026, reporting total revenue of RMB 4.58 billion, up 27.8% year-on-year. Revenue from innovative drugs reached RMB 3.887 billion,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147857859","title":"Simcere Pharma Appoints Zhu Da as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1147857859","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147857859?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238146,"startTime":"0","endTime":"0","summary":"Simcere Pharma (02096) has announced a change in its company secretarial roles. Mr. Wan Yushan has stepped down as Joint Company Secretary, effective August 20, 2026, while retaining his positions as...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660336292","title":"China's Simcere Pharmaceutical H1 Revenue Rises on Neuroscience, Autoimmune Drugs Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2660336292","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660336292?lang=en_us&edition=fundamental","pubTime":"2026-08-20 23:02","pubTimestamp":1787238137,"startTime":"0","endTime":"0","summary":"China's Simcere Pharmaceutical H1 revenue rises on neuroscience, autoimmune drugs strengthOverviewChina pharmaceutical maker's interim revenue grew 27.8% yr/yr for six months ended June 2026Net income","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H0N2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4149","LU1152091168.USD","MADE","IE00B5MMRT66.SGD","LU1993786604.SGD","LU1226288253.USD","BK1515","LU1152091754.HKD","LU0154245756.USD","HK0000165453.HKD","LU1328277881.USD","LU0289961442.SGD","LU0154245673.USD","LU0289739343.SGD","IE000M9KFDE8.USD","LU1008478684.HKD","LU0072913022.USD","BK4588","BK1521","LU0067412154.USD","KURE","IE00BZ08YS42.EUR","LU0203345920.USD","SG9999004220.SGD","BK4585","IE00B031HY20.USD","01093","CMI","LU1960683339.HKD","BK1191","LU0689626769.HKD","BK4567","LU1226287529.USD","LU0057025933.USD","IE0008368742.USD","LU0140636845.USD","LU0124676726.USD","BK4533","LU0880133367.SGD","LU0501845795.SGD","LU1226287875.USD","02096","LU1951186391.HKD","LU2463526074.USD","IE00BZ08YT58.USD","LU0511384066.AUD","IE00BZ08YR35.GBP","LU2039709279.SGD","BK1583","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":27,"pageCount":23,"totalSize":532,"code":"91000000","status":"200"}]}}